ACRAL LENTIGINOUS MELANOMA
Clinical trials for ACRAL LENTIGINOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new ACRAL LENTIGINOUS MELANOMA trials appear
Sign up with your email to follow new studies for ACRAL LENTIGINOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy before surgery shows promise for advanced melanoma
Disease control OngoingThis study looks at whether giving the immunotherapy drug pembrolizumab both before and after surgery works better than giving it only after surgery for people with stage III or IV high-risk melanoma. About 313 participants will receive pembrolizumab either before and after surge…
Matched conditions: ACRAL LENTIGINOUS MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 01:00 UTC
-
New drug shows promise in slowing advanced melanoma
Disease control OngoingThis study tests a drug called dinaciclib in 72 people with stage IV melanoma that has spread. The drug works by blocking enzymes that help cancer cells grow. The goal is to see if it can shrink tumors or slow the disease, and to check for side effects.
Matched conditions: ACRAL LENTIGINOUS MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 07, 2026 18:43 UTC